Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Atopic dermatitis poses mental health threat to kids

31 May 2020

Atopic dermatitis (AD) appears to be a significant mental health burden among children, a new study has found.

Researchers performed a cross-sectional analysis on 57,726,856 children, drawing data from the 2013–2017 US National Health Interview Survey. Child mental health was assessed through caregiver responses to the Strengths and Difficulties Questionnaire (SDQ), as well as through utilization of mental health services. The exposure variable was AD.

Of the study sample, 11.8 percent (n=6,807,687) had AD in the last 12 months. More than a quarter of these children (26.7 percent) had mental disorders with impairment (MDI), as opposed to only 17.7 percent of children without AD. The resulting difference was significant (p<0.001).

Moreover, severe MDI was almost twice as prevalent in AD vs non-AD children (10.9 percent vs 6.2 percent; p<0.001).

In addition, kids with recent AD were significantly more likely to have seen a mental health professional in the previous year (13.3 percent vs 8.3 percent; p<0.001). In this group, 19.9 percent with mild MDI and 53.5 percent with severe MDI had seen a professional.

Multivariable regression models, adjusted for demographic covariates and comorbidities, found that AD was significantly associated with MDI (adjusted odds ratio, 1.28, 95 percent confidence interval, 1.14–1.44).

“Importantly, our findings that many children with impaired mental health may not seek or receive medical attention for their symptoms exposes a critical practice gap,” the researchers said.

“Further work is needed to understand the potential barriers to mental health care in the paediatric AD population and to determine if successful treatment of AD results in better mental health outcomes,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.